This inventor holds 3 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2001-2006.
Location History:
- Gotenba, JP (2005)
- Shizuoka, JP (2001 - 2006)
Company Filing History:
Years Active: 2001-2006
Title: Toshiro Kozono: Innovator in Peptide Derivatives and Thrombopoietin-like Compounds
Introduction
Toshiro Kozono is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of peptide derivatives and compounds exhibiting thrombopoietin-like activities. With a total of 3 patents to his name, Kozono's work has the potential to impact medical science and therapeutic applications.
Latest Patents
Kozono's latest patents include innovative compounds and methods. One of his patents focuses on peptide derivatives, specifically a compound of Formula (1), which involves a complex between factor VIIa and human soluble tissue factor, along with a low-molecular weight reversible factor VIIa inhibitor. Another patent describes a method for computationally designing such inhibitors using coordinate data obtained from X-ray crystal structure analysis. Additionally, he has developed compounds that exhibit thrombopoietin-like activities, represented by a general formula that includes various functional groups and their pharmacologically acceptable salts.
Career Highlights
Kozono is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on cutting-edge research and development in the field of biochemistry. His contributions have been instrumental in advancing the understanding and application of peptide derivatives in medical science.
Collaborations
Kozono has collaborated with notable colleagues, including Shinya Fujiwara and Shojiro Kadono. These collaborations have fostered a productive research environment, leading to innovative discoveries and advancements in their respective fields.
Conclusion
Toshiro Kozono's work in peptide derivatives and thrombopoietin-like compounds showcases his innovative spirit and dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic solutions.